We are international
Donate
• videos TEXT SIZE   
webcasts from medical meetings    back

ASH 2011

The 53rd Annual Meeting of the American Society of Hematology (ASH) took place in San Diego, California December 10-13, 2011. The webcasts taped at the meeting are reports on the current status of some of the most interesting research in myeloma. Please be aware that at the time of posting, in some cases, the interviewees are reporting on interim data from incomplete clinical trials. Therefore not all the data presented are final results, and it is possible that results will be different when the data has matured with long-term follow-up. None of this research has yet been peer-reviewed and published in a medical journal.

Overviews
International Overviews
Bortezomib
Carfilzomib
Other Proteasome Inhibitors
Elotuzumab
Lenalidomide
Pomalidomide
Thalidomide
Other New Agents
Genetic Studies
Transplant
Maintenance Therapy
Second Primary Malignancies
Others
Best of ASH 2011 – What Patients Need to Know
Recorded January 25, 2012
with Dr. Brian G.M. Durie
Recording of Live Stream of Myeloma Questions and Controversies: New Developments in 2011 That Impact Diagnosis, Prognosis, and Treatment
Recorded Friday, December 9, 2011 at 6:30 PM Pacific Time

Dr. Anderson - An Overview of ASH 2011
Kenneth Anderson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, USA
Dr. Gertz: An Overview of ASH 2011
Morie Gertz, MD
Mayo Clinic
Rochester, Minnesota, USA

Dr. Rajkumar - An Overview of ASH 2011
S. Vincent Rajkumar, MD
Mayo Clinic College of Medicine
Rochester, Minnesota, USA